Empiric therapy for infections in the febrile, neutropenic, compromised host
- 1 January 1995
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 79 (3) , 559-580
- https://doi.org/10.1016/s0025-7125(16)30057-8
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Escherichia coli Resistant to Fluoroquinolones in Patients with Cancer and NeutropeniaNew England Journal of Medicine, 1994
- Bacteremia Due to Viridans Streptococcus in Neutropenic Patients with Cancer: Clinical Spectrum and Risk FactorsClinical Infectious Diseases, 1994
- An open trial of cefoperazone plus sulbactam for the treatment of fever in cancer patientsJournal of Antimicrobial Chemotherapy, 1993
- Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patientsAntimicrobial Agents and Chemotherapy, 1992
- Fungal infections in cancer patients: An international autopsy surveyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- β-Lactam regimens for the febrile neutropenic patientCancer, 1990
- A prospective, randomized comparison of ceftazidime and ciprofloxacin as initial empiric therapy in neutropenic patients with feverThe American Journal of Medicine, 1989
- Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patientsAntimicrobial Agents and Chemotherapy, 1989
- Neutropenia, fever, and infectionThe American Journal of Medicine, 1984
- Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute LeukemiaAnnals of Internal Medicine, 1966